|
Quotes & Info
|
| HSP > SEC Filings for HSP > Form 8-K on 7-Jan-2013 | All Recent SEC Filings |
7-Jan-2013
Change in Directors or Principal Officers, Financial Statements and Exhibits
On December 31, 2012, the change in control agreements with Hospira, Inc.'s ("Hospira") chief executive officer, chief financial officer and its other named executive officers expired pursuant to such agreements' terms. Effective January 1, 2013, those officers are entering into new change in control agreements with Hospira.
The new change in control agreements each have a three-year term and do not automatically renew at the end of such term. Hospira's responsibility to make payments under the agreements are conditioned on the occurrence of both a change in control (or potential change in control) and either the officer terminating for good reason (which includes, among other things, reduction in responsibility, reduction in salary, bonus or other compensation and benefits or relocation of the officer) or being terminated other than for cause or permanent disability during the two-year period following the change in control. The new agreements do not include excise tax gross-up provisions, but instead provide that the officer will receive the higher amount (after tax) of (1) the entire severance amount specified, with the officer personally paying any excise tax, or (2) a severance amount capped at the Internal Revenue Code Section 280G safe harbor limit. The benefits that those officers are entitled to receive are otherwise similar to those set forth in their previous change in control agreements. For a detailed description of those benefits, please see Hospira's 2012 Proxy Statement, which was filed with the Securities and Exchange Commission on March 23, 2012.
The foregoing descriptions of the change in control agreements are qualified in their entirety by reference to the full text of the agreements, which agreement with F. Michael Ball is attached hereto as Exhibit 10.1, and which form of agreement with Brian J. Smith, Thomas E. Werner, and Sumant Ramachandra is attached hereto as Exhibit 10.2. The exhibits are incorporated herein by reference.
(d) Exhibits
Exhibit No. Exhibit
10.1 Change in Control Agreement, dated January 1, 2013, between Hospira
and F. Michael Ball
10.2 Form of Change in Control Agreement, dated January 1, 2013, between
Hospira and each of Brian J. Smith, Thomas E. Werner, and Sumant
Ramachandra
|
|
|